Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck Serono’s Christoph Schnorr joins Quintiles

pharmafile | October 24, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Christoph Schnorr, Quintiles 

Dr Christoph Schnorr has joined Quintiles as head of its European Research and Development consulting practice.
 
Schnorr joins quintiles from Merck Serono where he was head of Development Operations, with oversight for all development functions including: Medical Science and Innovation, Global Clinical Operations, the Chief Medical Office and Regulatory Affairs.
 
A physician by training, and with twenty years’ experience in the pharmaceutical industry, Schnorr brings extensive expertise across the whole drug development spectrum to the firm.

Related Content

ims_health_quintiles

Quintiles to merge with IMS Health

IMS Health (NYSE: IMS) and Quintiles (NYSE: Q) have announced that a definitive merger agreement …

Contract research news in brief

Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles …

Contract research news in brief

Synteract agrees to by Harrison Clinical Research, WuXi forges JV with PR, plus appointments and …

The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025